New diabetes clinical trial: Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept: A US Real-World Evidence Study

Published on: August 04, 2025 at 11:00PM
Conditions: Retinal Vasculitis
Interventions: Drug: aflibercept 2mg
Sponsors: Regeneron Pharmaceuticals
Recruiting
https://ift.tt/loYutCw